$0.59
▼ $0.00
(-0.51%)
Vol 172K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$95.0M
ROE
-206.5%
D/E
139.28
Beta
0.58
52W
$1–$7
Wall Street Consensus
10 analysts · Apr 20263
Strong Buy
5
Buy
2
Hold
0
Sell
0
Strong Sell
80.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 0.0%
Next Report
May 12, 2026
EPS Estimate: $-0.29
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.29 | — | — |
| Dec 2025 | $-0.42 | $-0.73 | $-0.31 |
| Sep 2025 | $-0.42 | $-0.52 | $-0.10 |
| Jun 2025 | $-0.36 | $-0.40 | $-0.04 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Net Income | — | -$4.3M | -$5.0M | -$6.0M | -$7.8M | -$10.8M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -206.5% | -156.7% | -156.7% | -156.7% | -206.5% | -206.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 139.28 | 139.28 | 139.28 | 139.28 | 139.28 | 139.28 |
| Current Ratio | 5.45 | 5.45 | 5.45 | 5.45 | 4.04 | 4.04 |
Key Ratios
ROA (TTM)
-116.6%
P/B
3.3
EPS (TTM)
$-1.60
CF/Share
$-10.97
52W High
$7.20
52W Low
$1.42
$1.42
52-Week Range
$7.20
Financial Health
Free Cash Flow
-$4.9M
Net Debt
-$1.8M
Cash
$11.5M
Total Debt
$9.7M
As of Dec 31, 2025
How does CALC compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
CALC valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
3.3
▲
56%
above
peers
(2.1)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
CALC profitability vs Pharmaceuticals peers
ROE
-206.5%
▼
281%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-116.6%
▼
211%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
CALC financial health vs Pharmaceuticals peers
D/E ratio
139.3
▲
8944%
above
peers
(1.5)
vs Peers
vs Industry
High debt
Current ratio
4.0
▲
20%
above
peers
(3.4)
vs Peers
vs Industry
Below avg
Beta
0.6
▼
38%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
CALC fundamentals radar
CALC
Peer median
Industry
CALC profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CALC vs peers: key metrics
Top Holders
Top 5: 53.2%Deerfield Management Compan…
22.96%
$740K
Soleus Capital Management, …
12.08%
$389K
Aisling Capital Management …
9.20%
$297K
Vanguard Group Inc
7.20%
$232K
Geode Capital Management, L…
1.76%
$57K
As of Dec 31, 2025